HomeChoice PRO Automated Peritoneal Dialysis (PD) System 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Baxter Healthcare 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-03-19
  • 사례 출판 날짜
    2014-03-19
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: baxter homechoice pro automated peritoneal dialysis (pd) system the australia therapeutic goods administration (tga) posted a medical device safety alert concerning homechoice pro automated peritoneal dialysis (pd) system with product code r5c8320, manufactured by baxter healthcare. the manufacturer is implementing additional warning in homechoice/homechoice pro device product labelling related to patients more vulnerable to unintended increased intraperitoneal volume (iipv), also known as overfill. specific populations using pd therapy including neonates, infants, small children and any patient with significant heart or lung disease are more vulnerable to the negative effects of excessive retention of fluid in the peritoneal cavity that may be related to their dialysis therapy. overfilling with dialysate (iipv) or not draining enough fluid during pd therapy can result in excess fluid in the abdomen accompanied by patient symptoms. the manufacturer has contacted the suppliers (primarily hospitals) of homechoice pro automated peritoneal dialysis units to provide further information about the recall for product correction and instructions to contact affected patients. the manufacturer also advises customers that if unintended increased intraperitoneal volume (overfill) is suspected, they should immediately initiate a manual drain and contact their treating health professional. for details, please refer to tga websites:http://www.Tga.Gov.Au/sara/arn-detail.Aspx?k=rc-2014-rn-00304-1 and http://www.Tga.Gov.Au/safety/alerts-device-automated-peritoneal-dialysis-system-140318.Htm if you are in possession of the affected products, please contact your supplier for necessary actions. posted on 19 march 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Baxter HomeChoice PRO Automated Peritoneal Dialysis (PD) System
  • Manufacturer

Manufacturer